Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trials in the elderly.

E Perucca1, A Richens

  • 1Clinical Pharmacology Unit, University of Pavia, Piazza Botta 10, 27100, Pavia, Italy. perucca@unipv.it

Epilepsy Research
|July 20, 2001
PubMed
Summary
This summary is machine-generated.

Epilepsy in older adults presents unique challenges, with increased seizure incidence and higher risks of adverse drug effects from antiepileptic drugs (AEDs). Specific clinical trials are needed to optimize treatment for this population.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of generic substitution of anticonvulsants on the treatment of epilepsy.

CNS drugs·2013
Same author

Inhibition of phenytoin metabolism by sulthiame in epileptic patients.

British journal of clinical pharmacology·2012
Same author

Effect of diazepam on oculomotor balance.

British journal of clinical pharmacology·2012
Same author

Rate of elimination of tracer doses of phenytoin at different steady-state serum phenytoin concentrations in epileptic patients.

British journal of clinical pharmacology·2012
Same author

The influence of elevated plasma hydrocortisone concentrations on antipyrine metabolism in man.

British journal of clinical pharmacology·2012
Same author

α-adrenoceptor blocking drugs, pressor responses to noradrenaline, and the ankle jerk in man.

British journal of clinical pharmacology·2012
Same journal

Comment on "Predictors of surgical outcome in frontal lobe epilepsy: Experience from a single-center cohort in Latin America".

Epilepsy research·2026
Same journal

Response to: "A critical appraisal of principal component analysis of antiseizure medication-induced hostility/aggression and factor analysis of levetiracetam".

Epilepsy research·2026
Same journal

Access to inpatient video-EEG monitoring for patients with frequent seizure-related emergency visits.

Epilepsy research·2026
Same journal

Effect of the ketogenic diet on absence seizures in rats with genetic absence epilepsy.

Epilepsy research·2026
Same journal

Diagnostic accuracy of artificial intelligence models for seizure outcome prediction after epilepsy surgery: A systematic review and meta-analysis.

Epilepsy research·2026
Same journal

Quality assessment of persian epilepsy mobile applications: A systematic review using uMARS and DISCERN.

Epilepsy research·2026
See all related articles

Area of Science:

  • Geriatric Medicine
  • Neurology
  • Clinical Pharmacology

Background:

  • Epilepsy presentation and incidence vary significantly with age.
  • Older adults experience a higher prevalence of symptomatic seizures linked to underlying brain conditions.
  • Age-related physiological changes impact the metabolism and response to antiepileptic drugs (AEDs).

Purpose of the Study:

  • To highlight the distinct characteristics of epilepsy in the elderly.
  • To discuss the challenges in managing antiepileptic drug (AED) therapy in older individuals.
  • To advocate for age-specific clinical trials in epilepsy drug development.

Main Methods:

  • Review of existing literature on geriatric epilepsy and pharmacotherapy.
  • Analysis of age-related changes in hepatic and renal function.

Related Experiment Videos

  • Pharmacodynamic and pharmacokinetic considerations in elderly patients.

    • Main Results:

    • Seizure incidence rises sharply with age.
    • Elderly patients are more prone to adverse drug effects from AEDs.
    • The efficacy of AEDs in the elderly compared to younger populations remains uncertain.

    Conclusions:

    • Epilepsy management in the elderly requires careful consideration of age-related factors.
    • Pharmacokinetic and pharmacodynamic alterations necessitate individualized treatment approaches.
    • Dedicated clinical trials in elderly populations are crucial for advancing epilepsy care and drug development.